Ventyx Biosciences, Inc. 3 SEC Filings

Filed On	Filing
09 Sep 2024	Form 3: Gonzales Roy, Senior VP, Finance Holds 743 shares of Common Stock
13 Aug 2024	Form 3: Forman Mark S, Chief Medical Officer No securities owned
17 May 2024	Form 3: Moore Matthew Richard, Chief Operating Officer No securities owned
12 Jan 2023	Form 3: Cadoret-Manier Onaiza, Director No securities owned
12 Jan 2023	Form 3: Hulme Allison, Director No securities owned
09 May 2022	Form 3: Sandborn William J., See Remarks Holds 48,389 shares of Common Stock
20 Oct 2021	Form 3: Nsv Investments I, L.p., 10% owner
20 Oct 2021	Form 3: Gujrathi Sheila, Director
20 Oct 2021	Form 3: Auster Martin, Chief Financial Officer Holds 95,296 shares of Common Stock
20 Oct 2021	Form 3: White William Richard, Director
20 Oct 2021	Form 3: Choksey Jigar, Director No securities owned
20 Oct 2021	Form 3: Gaster Richard, Director No securities owned
20 Oct 2021	Form 3: Drappa Jorn, Chief Medical Officer
20 Oct 2021	Form 3: Krueger Christopher W, Chief Business Officer Holds 183,331 shares of Common Stock
20 Oct 2021	Form 3: venBio Global Strategic Fund III, L.p., 10% owner and 4 others Holds 1,014,267 shares of Common Stock
20 Oct 2021	Form 3: Nuss John, Chief Scientific Officer Holds 308,696 shares of Common Stock
20 Oct 2021	Form 3: Mohan Raju, Director Holds 1,841,811 shares of Common Stock
20 Oct 2021	Form 3: Subramaniam Somu, Director
20 Oct 2021	Form 3: Royston Aaron, Director Holds 1,014,267 shares of Common Stock
20 Oct 2021	Form 3: Cormorant Asset Management, Lp, 10% owner and 3 others

Comments